EPARs human use - Truvada//Emtricitabine and tenofovir disoproxil (as fumarate)

FICHA FARMACOLÓGICA de Emtricitabine and tenofovir disoproxil (as fumarate). Contiene la Monografía en distintos idiomas (de la Comunidad Económica Europea), así como la discusión científica que sustenta su aprobación terapéutica. Para acceder a la monografía en idioma español, hacer doble clik en la sigla (es) en la fila que se sitúa más abajo del centro de la página oficial. Cerasale. JUNIO 06, 2009.-
abrir aquí:
EPARs for authorised medicinal products for human use - Truvada

Active Substance
Emtricitabine and tenofovir disoproxil (as fumarate)
Modified International Nonproprietary Name or Common Name
Emtricitabine and tenofovir disoproxil (as fumarate)
Pharmaco-therapeutic Group
Nucleoside and nucleotide reverse transcriptase inhibitors
ATC Code
J05AR03

Therapeutic Indication:
Truvada is a fixed dose combination of emtricitabine and tenofovir disoproxil fumarate. It is indicated in antiretroviral combination therapy for the treatment of HIV-1 infected adults.
The demonstration of the benefit of the combination emtricitabine and tenofovir disoproxil fumarate in antiretroviral therapy is based solely on studies performed in treatment-naïve patients.

Date of issue of Marketing Authorisation valid throughout the European Union
21 February 2005